200602-psychofarmaca.pdf - Wetenschappelijk Tijdschrift Autisme

Literatuur
Aman, M.G., Arnold, L.E., McDougle, C.J.,
Vitiello, B., Scahill, L., Davies, M., McCracken, J.T. et
al. 2005. Acute and long-term safety and tolerability
of risperidone in children with autism. J Child Adolesc
Psychopharmacol. 15:869-84.
Arnold, L.E., Vitiello, B., McDougle, C., Scahill, L.,
Shah, B., Gonzalez, N.M., Chuang, S., Davies, M. et
al 2003. Parent-defined target symptoms respond to
risperidone in RUPP autism study: customer approach
to clinical trials. J Am Acad Child Adolesc Psychiatry.
42:1443-50.
Belsito, K.M., Law, P.A., Kirk, K.S., Landa, R.J.,
Zimmerman, A.W. (2001). Lamotrigine therapy for
autistic disorder: a randomized, double-blind, placebocontrolled
trial. J Autism Dev Disord. 31:175-81.
Buitelaar, J.K. & Willemsen-Swinkels, S.H.N. (2000)
Medication treatment in subjects with autistic spectrum
disorders. Eur Child Adolesc Psychiat 9:I85-I97.
Buitelaar, J.K., van der Gaag, R.J., Van der Hoeven,
J., (1998) Buspirone in the management of anxiety
and irritability in children with pervasive developmental
disorders: results of an open-label study. J Clin Psychiatry.
59:56-9.
Campbell, M., Armenteros, J.L., Malone, R.P.,
Adams, P.B., Eisenberg, Z.W., Overall, J.W. (1997).
Neuroleptic-related dyskinesias in autistic children: a
prospective, longitudinal study.
J Am Acad Child Adolesc Psychiatry. 36:835-43.
Campbell, M., Anderson, L.T., Small, A.M., Perry,
R., Green, W.H., Caplan, R. (1982). The effects of
haloperidol on learning and behavior in autistic children.
J Autism Dev Disord. 12:167-75.
Chez, M.G., Buchanan, C.P., Aimonovitch, M.C.,
Becker, M., Schaefer, K., Black, C., Komen, J. (2002).
Double-blind, placebo-controlled study of L-carnosine
supplementation in children with autistic spectrum
disorders. J Child Neurol.17:833-7.
Fankhauser, M.P., Karumanchi, V.C., German, M.L.
Yates, A., Karumanchi, S.D. (1992) A double-blind,
placebo controlled study of the efficacy of transdermal
clonidine in autism. J Clin Psychiat 53: 77-82.
Handen, B.L., Johnson, C.R., Lubetsky, M. (2000)
Efficacy of methylphenidate among children with autism
and symptoms of attention-deficit hyperactivity disorder.
J Autism Dev Disord. 30:245-55.
Hellings, J.A., Weckbaugh, M., Nickel, E.J., Cain,
S.E., Zarcone, J.R., Reese, R.M., Hall, S., et al. (2005).
A double-blind, placebo-controlled study of valproate
for aggression in youth with pervasive developmental
disorders. J Child Adolesc Psychopharmacol. 15:682-92.
Hollander, E., Phillips, A., Chaplin, W., Zagursky,
K., Novotny, S., Wasserman, S., Iyengar, R. (2005). A
placebo controlled crossover trial of liquid fluoxetine on
repetitive behaviors in childhood and adolescent autism.
Neuropsychopharmacology. 30:582-9.
Hollander, E., Soorya, L., Wasserman, S., Esposito,
K., Chaplin, W., Anagnostou, E. (2006).
Divalproex sodium vs. placebo in the treatment of
repetitive behaviours in autism spectrum disorder. Int J
Neuropsychopharmacol. 9:209-13.
Jaselskis, C., Cook, E.H., Fletcher, K.E., Leventhal,
B. (1992). Clonidine treatment of hyperactive and
impulsive children with autistic disorder. J Clin.
Psychopharmacology 12:322-327.
Jou, R.J., Handen, B.L., Hardan, A.Y. (2005)
Retrospective assessment of atomoxetine in children and
adolescents with pervasive developmental disorders. J
Child Adolesc Psychopharmacol. 15:325-30.
King, B.H., Wright, D.M., Handen, B.L., Sikich,
L., Zimmerman, A.W., McMahon, W., Cantwell,
E. et al. (2001). Double-blind, placebo-controlled
study of amantadine hydrochloride in the treatment
of children with autistic disorder. J Am Acad Child
Adolesc Psychiatry. 40:658-65.
Kolevzon, A., Mathewson, K.A., Hollander, E. (2006)
Selective serotonin reuptake inhibitors in autism: a review
of efficacy and tolerability. J Clin Psychiatry. 67:407-14.
McCracken, J.T., McGough, J., Shah, B., Cronin,
P., Hong, D., Aman, M.G., Arnold, L.E. et al. (2002)
Risperidone in children with autism and serious
behavioral problems. N Engl J Med. 347:314-21.
advertentie
Paavonen, E.J., Nieminen – von Wendt, T., Vanhala,
R., Aronen, E.T., von Wendt, L. (2003). Effectiveness
of melatonin in the treatment of sleep disturbances
in children with Asperger disorder. J Child Adolesc
Psychopharmacol. 13:83-95.
Quintana, H., Birmaher, B., Stedge, D., Lennon,
S., Freed, J., Bridge, J., Greenhill, L. (1995) Use of
methylfenidate in the treatment of children with autistic
disorder. J Autism Dev Disord. 25:283-294, 1995.
Smits, M.G., van Stel, H.F., van der Heijden, K.,
Meijer, A.M., Coenen, A.M., Kerkhof, G.A. (2003).
Melatonin improves health status and sleep in children
with idiopathic chronic sleep-onset insomnia: a
randomized placebo-controlled trial. J Am Acad Child
Adolesc Psychiatry. 42:1286-93.
Stigler, K,A., Desmond, L.A., Posey, D.J., Wiegand,
R.E., McDougle, C.J. (2004) A naturalistic retrospective
analysis of psychostimulants in pervasive developmental
disorders. J Child Adolesc psychopharmacol. 14:49-56.
Troost, P.W. (2006) Pharmacological Treatment in
Children with Autism Spectrum Disorders. PhD Thesis,
University Medical Center Groningen.
77
nummer 2 • augustus 2006